scholarly journals Co -occurring Mental Disorders among In-patients in a Substance use Disorder Treatment Center in Plateau State, Nigeria

2020 ◽  
Vol 3 (1) ◽  
pp. 223-229
Author(s):  
D M Makput
Keyword(s):  
Substance Use ◽  
Drug Abuse ◽  
Mental Disorders ◽  
Substance Use Disorders ◽  
Substance Use Disorder ◽  
Addiction Treatment ◽  
Treatment Center ◽  
Post Traumatic Stress ◽  
Functional Abnormality ◽  
Plateau State

Patients with psychoactive substance use disorders (SUD) often have co- occurring medical and mental disorders. This occurs as a result of a number of factors, for instance, drug abuse may facilitate the full expression of a latent psychiatric disorder; mental disorder may lead to SUD (drugs used for self- medication; or both SUD and mental disorders are caused by the same underlying brain deficit such as genetic vulnerability, neurotransmitter abnormality, structural or functional abnormality, and so on. After obtaining ethical clearance, the case notes of all patients who were admitted in the Centre for Addiction Treatment and Research, (CATR) Vom, Plateau state throughout the first quarter of year 2019 were traced. A systematic random sample of every third consecutive patient was selected beginning with the first patient admitted and relevant data were collected and analyzed. A total of fourty- eight (48) in-patients were analyzed. Ninety -four percent (94%) of the patients were males, the mean age of 23.6 + 5 years with 46% being below 25 years of age. Fourty-six percent (46%) had cannabis as their primary drug followed by alcohol (32%) and opioids (28%). Only 1 % had a history of injecting drug use. Twenty-nine percent (29%) of the SUD patients had co-occurring depression, nine percent (8%) had anxiety disorder, and five percent (4%) had Post Traumatic Stress Disorder (PTSD) in addition to their substance use disorder. In line with sustainable development goals (SDG) goal 3.5 which seeks to “strengthen prevention and treatment of substance abuse including narcotics drug abuse and harmful use of alcohol”; identifying co-occurring mental disorders among patients with substance use disorders is one way of moving closer towards achieving this SDG.

scholarly journals Co -occurring Mental Disorders among In-patients in a Substance use Disorder Treatment Center in Plateau State, Nigeria

2020 ◽  
Vol 3 (1) ◽  
pp. 223-229
Author(s):  
D M Makput
Keyword(s):  
Substance Use ◽  
Drug Abuse ◽  
Mental Disorders ◽  
Substance Use Disorders ◽  
Substance Use Disorder ◽  
Addiction Treatment ◽  
Treatment Center ◽  
Post Traumatic Stress ◽  
Functional Abnormality ◽  
Plateau State

Patients with psychoactive substance use disorders (SUD) often have co- occurring medical and mental disorders. This occurs as a result of a number of factors, for instance, drug abuse may facilitate the full expression of a latent psychiatric disorder; mental disorder may lead to SUD (drugs used for self- medication; or both SUD and mental disorders are caused by the same underlying brain deficit such as genetic vulnerability, neurotransmitter abnormality, structural or functional abnormality, and so on. After obtaining ethical clearance, the case notes of all patients who were admitted in the Centre for Addiction Treatment and Research, (CATR) Vom, Plateau state throughout the first quarter of year 2019 were traced. A systematic random sample of every third consecutive patient was selected beginning with the first patient admitted and relevant data were collected and analyzed. A total of fourty- eight (48) in-patients were analyzed. Ninety -four percent (94%) of the patients were males, the mean age of 23.6 + 5 years with 46% being below 25 years of age. Fourty-six percent (46%) had cannabis as their primary drug followed by alcohol (32%) and opioids (28%). Only 1 % had a history of injecting drug use. Twenty-nine percent (29%) of the SUD patients had co-occurring depression, nine percent (8%) had anxiety disorder, and five percent (4%) had Post Traumatic Stress Disorder (PTSD) in addition to their substance use disorder. In line with sustainable development goals (SDG) goal 3.5 which seeks to “strengthen prevention and treatment of substance abuse including narcotics drug abuse and harmful use of alcohol”; identifying co-occurring mental disorders among patients with substance use disorders is one way of moving closer towards achieving this SDG.

scholarly journals Co -occurring Mental Disorders among In-patients in a Substance use Disorder Treatment Center in Plateau State, Nigeria

2020 ◽  
Vol 3 (1) ◽  
pp. 223-229
Author(s):  
D M Makput
Keyword(s):  
Substance Use ◽  
Drug Abuse ◽  
Mental Disorders ◽  
Substance Use Disorders ◽  
Substance Use Disorder ◽  
Addiction Treatment ◽  
Treatment Center ◽  
Post Traumatic Stress ◽  
Functional Abnormality ◽  
Plateau State

Patients with psychoactive substance use disorders (SUD) often have co- occurring medical and mental disorders. This occurs as a result of a number of factors, for instance, drug abuse may facilitate the full expression of a latent psychiatric disorder; mental disorder may lead to SUD (drugs used for self- medication; or both SUD and mental disorders are caused by the same underlying brain deficit such as genetic vulnerability, neurotransmitter abnormality, structural or functional abnormality, and so on. After obtaining ethical clearance, the case notes of all patients who were admitted in the Centre for Addiction Treatment and Research, (CATR) Vom, Plateau state throughout the first quarter of year 2019 were traced. A systematic random sample of every third consecutive patient was selected beginning with the first patient admitted and relevant data were collected and analyzed. A total of fourty- eight (48) in-patients were analyzed. Ninety -four percent (94%) of the patients were males, the mean age of 23.6 + 5 years with 46% being below 25 years of age. Fourty-six percent (46%) had cannabis as their primary drug followed by alcohol (32%) and opioids (28%). Only 1 % had a history of injecting drug use. Twenty-nine percent (29%) of the SUD patients had co-occurring depression, nine percent (8%) had anxiety disorder, and five percent (4%) had Post Traumatic Stress Disorder (PTSD) in addition to their substance use disorder. In line with sustainable development goals (SDG) goal 3.5 which seeks to “strengthen prevention and treatment of substance abuse including narcotics drug abuse and harmful use of alcohol”; identifying co-occurring mental disorders among patients with substance use disorders is one way of moving closer towards achieving this SDG.

scholarly journals Co -occurring Mental Disorders among In-patients in a Substance use Disorder Treatment Center in Plateau State, Nigeria

2020 ◽  
Vol 3 (1) ◽  
pp. 223-229
Author(s):  
D M Makput
Keyword(s):  
Substance Use ◽  
Drug Abuse ◽  
Mental Disorders ◽  
Substance Use Disorders ◽  
Substance Use Disorder ◽  
Addiction Treatment ◽  
Treatment Center ◽  
Post Traumatic Stress ◽  
Functional Abnormality ◽  
Plateau State

Patients with psychoactive substance use disorders (SUD) often have co- occurring medical and mental disorders. This occurs as a result of a number of factors, for instance, drug abuse may facilitate the full expression of a latent psychiatric disorder; mental disorder may lead to SUD (drugs used for self- medication; or both SUD and mental disorders are caused by the same underlying brain deficit such as genetic vulnerability, neurotransmitter abnormality, structural or functional abnormality, and so on. After obtaining ethical clearance, the case notes of all patients who were admitted in the Centre for Addiction Treatment and Research, (CATR) Vom, Plateau state throughout the first quarter of year 2019 were traced. A systematic random sample of every third consecutive patient was selected beginning with the first patient admitted and relevant data were collected and analyzed. A total of fourty- eight (48) in-patients were analyzed. Ninety -four percent (94%) of the patients were males, the mean age of 23.6 + 5 years with 46% being below 25 years of age. Fourty-six percent (46%) had cannabis as their primary drug followed by alcohol (32%) and opioids (28%). Only 1 % had a history of injecting drug use. Twenty-nine percent (29%) of the SUD patients had co-occurring depression, nine percent (8%) had anxiety disorder, and five percent (4%) had Post Traumatic Stress Disorder (PTSD) in addition to their substance use disorder. In line with sustainable development goals (SDG) goal 3.5 which seeks to “strengthen prevention and treatment of substance abuse including narcotics drug abuse and harmful use of alcohol”; identifying co-occurring mental disorders among patients with substance use disorders is one way of moving closer towards achieving this SDG.

Co -occurring Mental Disorders among In-patients in a Substance use Disorder Treatment Center in Plateau State, Nigeria

2020 ◽  
Vol 3 (1) ◽  
pp. 223-229
Author(s):  
D M Makput
Keyword(s):  
Substance Use ◽  
Drug Abuse ◽  
Mental Disorders ◽  
Substance Use Disorders ◽  
Substance Use Disorder ◽  
Addiction Treatment ◽  
Treatment Center ◽  
Post Traumatic Stress ◽  
Functional Abnormality ◽  
Plateau State

Patients with psychoactive substance use disorders (SUD) often have co- occurring medical and mental disorders. This occurs as a result of a number of factors, for instance, drug abuse may facilitate the full expression of a latent psychiatric disorder; mental disorder may lead to SUD (drugs used for self- medication; or both SUD and mental disorders are caused by the same underlying brain deficit such as genetic vulnerability, neurotransmitter abnormality, structural or functional abnormality, and so on. After obtaining ethical clearance, the case notes of all patients who were admitted in the Centre for Addiction Treatment and Research, (CATR) Vom, Plateau state throughout the first quarter of year 2019 were traced. A systematic random sample of every third consecutive patient was selected beginning with the first patient admitted and relevant data were collected and analyzed. A total of fourty- eight (48) in-patients were analyzed. Ninety -four percent (94%) of the patients were males, the mean age of 23.6 + 5 years with 46% being below 25 years of age. Fourty-six percent (46%) had cannabis as their primary drug followed by alcohol (32%) and opioids (28%). Only 1 % had a history of injecting drug use. Twenty-nine percent (29%) of the SUD patients had co-occurring depression, nine percent (8%) had anxiety disorder, and five percent (4%) had Post Traumatic Stress Disorder (PTSD) in addition to their substance use disorder. In line with sustainable development goals (SDG) goal 3.5 which seeks to “strengthen prevention and treatment of substance abuse including narcotics drug abuse and harmful use of alcohol”; identifying co-occurring mental disorders among patients with substance use disorders is one way of moving closer towards achieving this SDG.

Outline of This Treatment Program

2014 ◽  
pp. 25-42
Author(s):  
Sudie E. Back ◽  
Edna B. Foa ◽  
Therese K. Killeen ◽  
Katherine L. Mills ◽  
Maree Teesson ◽  
...  
Keyword(s):  
Substance Use ◽  
Substance Use Disorders ◽  
Substance Use Disorder ◽  
Treatment Program ◽  
Post Traumatic Stress Disorder ◽  
Traumatic Stress ◽  
Post Traumatic Stress ◽  
Post Traumatic ◽  
Focus Questions

This chapter provides the therapist with an outline of the COPE treatment and components of each session (e.g. check-in, review homework, post-traumatic stress disorder [PTSD] focus, substance use disorder focus). Questions regarding who can deliver the therapy are addressed, as well as questions regarding the role of medications. Finally, special considerations for delivering treatment to patients with PTSD and comorbid substance use disorders are reviewed for the therapist.

Managing Substance Use Disorder

2019 ◽  
Author(s):  
Dennis C. Daley ◽  
Antoine B. Douaihy
Keyword(s):  
Substance Use ◽  
Social Services ◽  
Substance Use Disorders ◽  
Substance Use Disorder ◽  
Addiction Treatment ◽  
Medical Center ◽  
Direct Care ◽  
Extensive Experience ◽  
Medical Practitioners ◽  
Large Continuum

This practitioner guide reviews screening, assessment, and treatment of substance use disorders (SUDs). It is designed to accompany Managing Your Substance Use Disorder: Client Workbook and A Family Guide to Coping with Substance Use Disorders. The latter guide was added because each person with a SUD affects the family and concerned significant others. The information and strategies that the authors present can be used with clients who have any type of SUD. The guide focuses on strategies to reduce or stop substance use and change behaviors that challenge recovery. The information presented is derived from research, clinical, and recovery literature and from the authors’ extensive experience developing and managing a large continuum of clinical services, providing direct care, conducting quality improvement initiatives, participating in clinical trials, and teaching all disciplines in a large medical center and the community. This guide discusses professional approaches and attitudes toward individuals with SUDs, assessment, diagnostic formulation, psychosocial and pharmacotherapeutic treatments, and mutual support programs. It provides an overview of the recovery and relapse processes and practical strategies to address issues associated with SUDs. This guide is for practitioners from any discipline who encounter individuals with SUDs in addiction, mental health, psychiatric, private practice, or other settings such as social services and the criminal justice system. Even medical practitioners who do not specialize in addiction treatment can benefit from the information in this guide because individuals with SUDs are found in all types of healthcare settings.

Psychiatric Co-Occurring Disorders

2020 ◽  
pp. 349-378
Author(s):  
Kenneth B. Stoller
Keyword(s):  
Substance Use ◽  
Substance Use Disorders ◽  
Addiction Treatment ◽  
Negative Symptoms ◽  
Psychiatric Symptoms ◽  
Antidepressant Medication ◽  
Diagnostic Process ◽  
Post Traumatic Stress ◽  
Psychiatric Illnesses ◽  
Increased Risk

Substance use disorders commonly co-occur with psychiatric disorders. Psychiatric illnesses are associated with substance use disorders. Recognition of psychiatric symptoms, especially suicidal ideation, is essential. Factors such as substance use or withdrawal, related psychosocial stressors, and co-occurring somatic health problems complicate the diagnostic process. Addressing psychiatric symptoms is essential to optimize treatment of substance use disorders. Medications can help but may be unnecessary once substance use is stabilized. Other approaches include counseling, psychotherapy, case coordination, and inpatient/residential care. The affective disorders, especially bipolar disorder, are associated with substance use disorders. Depression is common and often improves with addiction treatment. For those who do not improve, antidepressant medication or psychotherapy may help. Anxiety disorders and post-traumatic stress disorder are associated with substance use disorders. If left unaddressed, persistent worry and anxiety worsen treatment outcomes. Although there are effective pharmacotherapies, psychotherapeutic approaches are a mainstay of treatment. Schizophrenia is particularly disabling and associated with an increased risk for substance use disorders. Antipsychotic medications can be effective, but persistent “negative” symptoms warrant comprehensive, supportive approaches with sufficient ancillary services. Those with personality disorders have high rates of substance use disorders and can be a challenge to treat. A strong team-based approach, psychosocial treatments, and sometimes medications can improve outcomes. Those with attention-deficit/hyperactivity disorder are at increased risk for substance use disorders. Impairing symptoms of inattention and impulsivity may persist into adulthood, complicating substance use disorder treatment engagement and outcomes. Medications can be helpful, but care must be taken when considering prescribing stimulants.

Performance-Based Practice: Clinical Dashboards for Addiction Treatment Retention

2020 ◽  
pp. 104973152097279
Author(s):  
David A. Patterson Silver Wolf ◽  
Autumn Asher BlackDeer ◽  
Sara Beeler-Stinn ◽  
Ken Zheng ◽  
Kristin Stazrad
Keyword(s):  
Substance Use ◽  
Pilot Study ◽  
Substance Use Disorders ◽  
Addiction Treatment ◽  
Treatment Retention ◽  
Treatment Center ◽  
Health Improvement ◽  
Evidence Based ◽  
Treatment Needs ◽  
The Impact

Purpose: Substance use disorders (SUDs) are on the rise, particularly concerning opioids, and existing services are still not adequately meeting treatment needs. Most treatment dropouts occur within the first few weeks of treatment, indicating health improvement is likely not occurring. In this study, a clinical dashboard tool has shown promising utility with increasing retention in SUD treatment. Method: This pilot study was designed to measure the effects of implementing a performance-based practice clinical dashboard tool and having a process for monitoring patients’ recovery in a Midwestern SUD treatment center. Results: The results demonstrated the efficacy of a clinical dashboard tool that complements therapists’ monitoring and measuring of their patients’ performance. Discussion: Results support a building knowledge base about the impact of real-time, evidence-based tools on the retention and support of clients seeking SUD treatment.

scholarly journals Prevalence of Undiagnosed Post Traumatic Stress Disorder among In-Patients in a Substance Use Disorder Treatment Centre in Nigeria

2018 ◽  
Vol 1 (2) ◽  
pp. 136-141
Author(s):  
D M Makput ◽  
N Dami ◽  
C G Piwuna ◽  
T N Haa ◽  
C Maton
Keyword(s):  
Substance Use ◽  
Substance Use Disorder ◽  
Post Traumatic Stress Disorder ◽  
Traumatic Stress ◽  
Addiction Treatment ◽  
Stress Disorder ◽  
Physical Symptoms ◽  
Check List ◽  
Post Traumatic Stress ◽  
Post Traumatic

Post traumatic stress disorder is a clinical disorder characterized by emotional and physical symptoms that may occur after exposure to a severely traumatic event. It occurs commonly as a co-morbid diagnosis with substance related disorders, as well as other psychiatric disorders.  We postulated that post traumatic stress disorder may be under- diagnosed in therapeutic wards where substance use disorders are treated. This study thus sought to determine the prevalence of undiagnosed post traumatic stress disorder   in a substance use disorder in-patient population. The posttraumatic stress disorder check list, Civilian version was administered to patients on admission at the Center for addiction treatment and research, Vom, Plateau state, Nigeria in June 2017. Socio-demographic data and information regarding substance use were also obtained from the patients. A total of 38 in-patients were analyzed and 8 (21%) met the Diagnostic and statistical manual of mental disorders (fourth edition) criteria for current post traumatic stress disorder. None of the patients had a diagnosis of post traumatic stress disorder   in their case notes prior to the post traumatic stress disorder check list administration in this study. Post traumatic stress disorder which is frequently co-morbid with substance abuse remains undiagnosed in many patients admitted to our therapeutic center.

Sign in / Sign up

Export Citation Format

Share Document